Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2026-01-04 @ 4:51 PM
Study NCT ID:
NCT02482805
Status:
COMPLETED
Last Update Posted:
2017-11-24
First Post:
2015-06-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Hormones and Social Anxiety Disorder Treatment
Sponsor:
Organization:
Raw JSON
{'hasResults': True, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D000072861', 'term': 'Phobia, Social'}], 'ancestors': [{'id': 'D010698', 'term': 'Phobic Disorders'}, {'id': 'D001008', 'term': 'Anxiety Disorders'}, {'id': 'D001523', 'term': 'Mental Disorders'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D015928', 'term': 'Cognitive Behavioral Therapy'}], 'ancestors': [{'id': 'D001521', 'term': 'Behavior Therapy'}, {'id': 'D011613', 'term': 'Psychotherapy'}, {'id': 'D004191', 'term': 'Behavioral Disciplines and Activities'}]}}, 'resultsSection': {'moreInfoModule': {'pointOfContact': {'email': 'michelledavis@utexas.edu', 'phone': '214-470-1371', 'title': 'Michelle Davis', 'organization': 'University of Texas at Austin'}, 'certainAgreement': {'piSponsorEmployee': False, 'restrictiveAgreement': False}}, 'adverseEventsModule': {'eventGroups': [{'id': 'EG000', 'title': 'Power Posing', 'description': 'Individuals hold two, 1-minute postures associated with dominance and high power prior to exposure therapy.\n\nCognitive Behavioral Therapy: Exposure therapy for social anxiety disorder', 'otherNumAtRisk': 26, 'otherNumAffected': 0, 'seriousNumAtRisk': 26, 'seriousNumAffected': 0}, {'id': 'EG001', 'title': 'Submissive Posing', 'description': 'Individuals hold two, 1-minute postures associated with submissiveness and low power prior to exposure therapy.\n\nCognitive Behavioral Therapy: Exposure therapy for social anxiety disorder', 'otherNumAtRisk': 27, 'otherNumAffected': 0, 'seriousNumAtRisk': 27, 'seriousNumAffected': 0}, {'id': 'EG002', 'title': 'Rest', 'description': 'Individuals rest (no postures) for 2 minutes prior to exposure therapy.\n\nCognitive Behavioral Therapy: Exposure therapy for social anxiety disorder', 'otherNumAtRisk': 20, 'otherNumAffected': 0, 'seriousNumAtRisk': 20, 'seriousNumAffected': 0}], 'frequencyThreshold': '0'}, 'outcomeMeasuresModule': {'outcomeMeasures': [{'type': 'PRIMARY', 'title': 'LSAS-performance Subscale', 'denoms': [{'units': 'Participants', 'counts': [{'value': '23', 'groupId': 'OG000'}, {'value': '26', 'groupId': 'OG001'}, {'value': '20', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Power Posing', 'description': 'Individuals hold two, 1-minute postures associated with dominance and high power prior to exposure therapy.\n\nCognitive Behavioral Therapy: Exposure therapy for social anxiety disorder'}, {'id': 'OG001', 'title': 'Submissive Posing', 'description': 'Individuals hold two, 1-minute postures associated with submissiveness and low power prior to exposure therapy.\n\nCognitive Behavioral Therapy: Exposure therapy for social anxiety disorder'}, {'id': 'OG002', 'title': 'Rest', 'description': 'Individuals rest (no postures) for 2 minutes prior to exposure therapy.\n\nCognitive Behavioral Therapy: Exposure therapy for social anxiety disorder'}], 'classes': [{'categories': [{'measurements': [{'value': '34.04', 'spread': '14.76', 'groupId': 'OG000'}, {'value': '32.54', 'spread': '8.74', 'groupId': 'OG001'}, {'value': '32.05', 'spread': '13.70', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': 'Scores at 1 week post-treatment', 'description': 'Liebowitz Social Anxiety Scale (LSAS)-Performance Subscale at pre- and 1-week post-treatment.\n\nThe Liebowitz Social Anxiety Scale (LSAS) - Performance Subscale is a subscale of a common measure of social anxiety symptom severity. This subscale consists of only 13 (of the total 24) items related to performance situations. Participants rate both their fear (0 to 3) and avoidance (0 to 3) of these 13 situations, where higher scores indicate worse social anxiety severity. The minimum possible score on this subscale is 0 and the maximum possible score is 78.', 'unitOfMeasure': 'units on a scale', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'populationDescription': '4 individuals did not complete LSAS at post-treatment; accordingly the analyses were conducted with only 69 individuals (versus the total sample size of 73) who had complete data.'}, {'type': 'PRIMARY', 'title': 'Subjective Units of Distress Scale (SUDs)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '23', 'groupId': 'OG000'}, {'value': '23', 'groupId': 'OG001'}, {'value': '20', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Power Posing', 'description': 'Individuals hold two, 1-minute postures associated with dominance and high power prior to exposure therapy.\n\nCognitive Behavioral Therapy: Exposure therapy for social anxiety disorder'}, {'id': 'OG001', 'title': 'Submissive Posing', 'description': 'Individuals hold two, 1-minute postures associated with submissiveness and low power prior to exposure therapy.\n\nCognitive Behavioral Therapy: Exposure therapy for social anxiety disorder'}, {'id': 'OG002', 'title': 'Rest', 'description': 'Individuals rest (no postures) for 2 minutes prior to exposure therapy.\n\nCognitive Behavioral Therapy: Exposure therapy for social anxiety disorder'}], 'classes': [{'categories': [{'measurements': [{'value': '59.26', 'spread': '14.43', 'groupId': 'OG000'}, {'value': '59.17', 'spread': '23.85', 'groupId': 'OG001'}, {'value': '48.75', 'spread': '19.79', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': 'Scores at 1 week post-treatment', 'description': 'Peak (max) SUDS ratings (0 to 100 scale) during treatment exposure and 1 week post-treatment exposure.\n\nPeak Subjective Units of Distress Scale (SUDS) is the maximum amount of fear experienced rated on a 0 to 100 point scale, where 0 indicates no anxiety and 100 indicates the maximum level of anxiety.', 'unitOfMeasure': 'units on a scale', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'populationDescription': '8 individuals did not complete the post-treatment exposure; accordingly the analyses were conducted with only 66 individuals (versus the total sample size of 73) who had complete data.'}, {'type': 'PRIMARY', 'title': 'Salivary Testosterone Levels', 'denoms': [{'units': 'Participants', 'counts': [{'value': '26', 'groupId': 'OG000'}, {'value': '27', 'groupId': 'OG001'}, {'value': '20', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Power Posing', 'description': 'Individuals hold two, 1-minute postures associated with dominance and high power prior to exposure therapy.\n\nCognitive Behavioral Therapy: Exposure therapy for social anxiety disorder'}, {'id': 'OG001', 'title': 'Submissive Posing', 'description': 'Individuals hold two, 1-minute postures associated with submissiveness and low power prior to exposure therapy.\n\nCognitive Behavioral Therapy: Exposure therapy for social anxiety disorder'}, {'id': 'OG002', 'title': 'Rest', 'description': 'Individuals rest (no postures) for 2 minutes prior to exposure therapy.\n\nCognitive Behavioral Therapy: Exposure therapy for social anxiety disorder'}], 'classes': [{'categories': [{'measurements': [{'value': '-2.31', 'spread': '10.82', 'groupId': 'OG000'}, {'value': '-0.88', 'spread': '33.31', 'groupId': 'OG001'}, {'value': '-1.47', 'spread': '54.56', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': 'Baseline and 20 minutes after posture manipulation', 'description': 'Saliva sample taken before posture manipulation and 20 minutes after. Outcome is the change from pre- to post-manipulation in testosterone levels.', 'unitOfMeasure': 'pg/mL', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}]}, 'participantFlowModule': {'groups': [{'id': 'FG000', 'title': 'Power Posing', 'description': 'Individuals hold two, 1-minute postures associated with dominance and high power prior to exposure therapy.\n\nCognitive Behavioral Therapy: Exposure therapy for social anxiety disorder'}, {'id': 'FG001', 'title': 'Submissive Posing', 'description': 'Individuals hold two, 1-minute postures associated with submissiveness and low power prior to exposure therapy.\n\nCognitive Behavioral Therapy: Exposure therapy for social anxiety disorder'}, {'id': 'FG002', 'title': 'Rest', 'description': 'Individuals rest (no postures) for 2 minutes prior to exposure therapy.\n\nCognitive Behavioral Therapy: Exposure therapy for social anxiety disorder'}], 'periods': [{'title': 'Overall Study', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '26'}, {'groupId': 'FG001', 'numSubjects': '27'}, {'groupId': 'FG002', 'numSubjects': '20'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '22'}, {'groupId': 'FG001', 'numSubjects': '23'}, {'groupId': 'FG002', 'numSubjects': '20'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '4'}, {'groupId': 'FG001', 'numSubjects': '4'}, {'groupId': 'FG002', 'numSubjects': '0'}]}], 'dropWithdraws': [{'type': 'Lost to Follow-up', 'reasons': [{'groupId': 'FG000', 'numSubjects': '4'}, {'groupId': 'FG001', 'numSubjects': '4'}, {'groupId': 'FG002', 'numSubjects': '0'}]}]}]}, 'baselineCharacteristicsModule': {'denoms': [{'units': 'Participants', 'counts': [{'value': '26', 'groupId': 'BG000'}, {'value': '27', 'groupId': 'BG001'}, {'value': '20', 'groupId': 'BG002'}, {'value': '73', 'groupId': 'BG003'}]}], 'groups': [{'id': 'BG000', 'title': 'Power Posing', 'description': 'Individuals hold two, 1-minute postures associated with dominance and high power prior to exposure therapy.\n\nCognitive Behavioral Therapy: Exposure therapy for social anxiety disorder'}, {'id': 'BG001', 'title': 'Submissive Posing', 'description': 'Individuals hold two, 1-minute postures associated with submissiveness and low power prior to exposure therapy.\n\nCognitive Behavioral Therapy: Exposure therapy for social anxiety disorder'}, {'id': 'BG002', 'title': 'Rest', 'description': 'Individuals rest (no postures) for 2 minutes prior to exposure therapy.\n\nCognitive Behavioral Therapy: Exposure therapy for social anxiety disorder'}, {'id': 'BG003', 'title': 'Total', 'description': 'Total of all reporting groups'}], 'measures': [{'title': 'Age, Continuous', 'classes': [{'categories': [{'measurements': [{'value': '26.88', 'spread': '6.99', 'groupId': 'BG000'}, {'value': '25.26', 'spread': '8.99', 'groupId': 'BG001'}, {'value': '24.60', 'spread': '5.83', 'groupId': 'BG002'}, {'value': '25.66', 'spread': '7.48', 'groupId': 'BG003'}]}]}], 'paramType': 'MEAN', 'unitOfMeasure': 'years', 'dispersionType': 'STANDARD_DEVIATION'}, {'title': 'Sex: Female, Male', 'classes': [{'categories': [{'title': 'Female', 'measurements': [{'value': '18', 'groupId': 'BG000'}, {'value': '18', 'groupId': 'BG001'}, {'value': '16', 'groupId': 'BG002'}, {'value': '52', 'groupId': 'BG003'}]}, {'title': 'Male', 'measurements': [{'value': '8', 'groupId': 'BG000'}, {'value': '9', 'groupId': 'BG001'}, {'value': '4', 'groupId': 'BG002'}, {'value': '21', 'groupId': 'BG003'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Ethnicity (NIH/OMB)', 'classes': [{'categories': [{'title': 'Hispanic or Latino', 'measurements': [{'value': '5', 'groupId': 'BG000'}, {'value': '9', 'groupId': 'BG001'}, {'value': '3', 'groupId': 'BG002'}, {'value': '17', 'groupId': 'BG003'}]}, {'title': 'Not Hispanic or Latino', 'measurements': [{'value': '20', 'groupId': 'BG000'}, {'value': '17', 'groupId': 'BG001'}, {'value': '16', 'groupId': 'BG002'}, {'value': '53', 'groupId': 'BG003'}]}, {'title': 'Unknown or Not Reported', 'measurements': [{'value': '1', 'groupId': 'BG000'}, {'value': '1', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '3', 'groupId': 'BG003'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Race (NIH/OMB)', 'classes': [{'categories': [{'title': 'American Indian or Alaska Native', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}]}, {'title': 'Asian', 'measurements': [{'value': '6', 'groupId': 'BG000'}, {'value': '5', 'groupId': 'BG001'}, {'value': '3', 'groupId': 'BG002'}, {'value': '14', 'groupId': 'BG003'}]}, {'title': 'Native Hawaiian or Other Pacific Islander', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}]}, {'title': 'Black or African American', 'measurements': [{'value': '2', 'groupId': 'BG000'}, {'value': '2', 'groupId': 'BG001'}, {'value': '3', 'groupId': 'BG002'}, {'value': '7', 'groupId': 'BG003'}]}, {'title': 'White', 'measurements': [{'value': '14', 'groupId': 'BG000'}, {'value': '14', 'groupId': 'BG001'}, {'value': '11', 'groupId': 'BG002'}, {'value': '39', 'groupId': 'BG003'}]}, {'title': 'More than one race', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}]}, {'title': 'Unknown or Not Reported', 'measurements': [{'value': '4', 'groupId': 'BG000'}, {'value': '6', 'groupId': 'BG001'}, {'value': '3', 'groupId': 'BG002'}, {'value': '13', 'groupId': 'BG003'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Region of Enrollment', 'classes': [{'title': 'United States', 'categories': [{'measurements': [{'value': '26', 'groupId': 'BG000'}, {'value': '27', 'groupId': 'BG001'}, {'value': '20', 'groupId': 'BG002'}, {'value': '73', 'groupId': 'BG003'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'LSAS-performance', 'classes': [{'categories': [{'measurements': [{'value': '37.96', 'spread': '14.39', 'groupId': 'BG000'}, {'value': '36.19', 'spread': '10.92', 'groupId': 'BG001'}, {'value': '37.85', 'spread': '10.16', 'groupId': 'BG002'}, {'value': '37.27', 'spread': '11.96', 'groupId': 'BG003'}]}]}], 'paramType': 'MEAN', 'description': 'The Liebowitz Social Anxiety Scale (LSAS) - Performance Subscale is a subscale of a common measure of social anxiety symptom severity. This subscale consists of only 13 (of the total 24) items related to performance situations. Participants rate both their fear (0 to 3) and avoidance (0 to 3) of these 13 situations, where higher scores indicate worse social anxiety severity. The minimum possible score on this subscale is 0 and the maximum possible score is 78.', 'unitOfMeasure': 'units on a scale', 'dispersionType': 'STANDARD_DEVIATION'}, {'title': 'Peak SUDS during exposure', 'classes': [{'categories': [{'measurements': [{'value': '76.31', 'spread': '14.86', 'groupId': 'BG000'}, {'value': '77.74', 'spread': '15.03', 'groupId': 'BG001'}, {'value': '77.50', 'spread': '11.20', 'groupId': 'BG002'}, {'value': '77.16', 'spread': '13.85', 'groupId': 'BG003'}]}]}], 'paramType': 'MEAN', 'description': 'Peak Subjective Units of Distress Scale (SUDS) is the maximum amount of fear experienced rated on a 0 to 100 point scale, where 0 indicates no anxiety and 100 indicates the maximum level of anxiety.', 'unitOfMeasure': 'units on a scale', 'dispersionType': 'STANDARD_DEVIATION'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'SINGLE', 'whoMasked': ['PARTICIPANT']}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 73}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2015-07'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2017-10', 'completionDateStruct': {'date': '2017-04', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2017-10-19', 'studyFirstSubmitDate': '2015-06-17', 'resultsFirstSubmitDate': '2017-05-10', 'studyFirstSubmitQcDate': '2015-06-23', 'lastUpdatePostDateStruct': {'date': '2017-11-24', 'type': 'ACTUAL'}, 'resultsFirstSubmitQcDate': '2017-10-06', 'studyFirstPostDateStruct': {'date': '2015-06-26', 'type': 'ESTIMATED'}, 'resultsFirstPostDateStruct': {'date': '2017-10-16', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2016-12', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'LSAS-performance Subscale', 'timeFrame': 'Scores at 1 week post-treatment', 'description': 'Liebowitz Social Anxiety Scale (LSAS)-Performance Subscale at pre- and 1-week post-treatment.\n\nThe Liebowitz Social Anxiety Scale (LSAS) - Performance Subscale is a subscale of a common measure of social anxiety symptom severity. This subscale consists of only 13 (of the total 24) items related to performance situations. Participants rate both their fear (0 to 3) and avoidance (0 to 3) of these 13 situations, where higher scores indicate worse social anxiety severity. The minimum possible score on this subscale is 0 and the maximum possible score is 78.'}, {'measure': 'Subjective Units of Distress Scale (SUDs)', 'timeFrame': 'Scores at 1 week post-treatment', 'description': 'Peak (max) SUDS ratings (0 to 100 scale) during treatment exposure and 1 week post-treatment exposure.\n\nPeak Subjective Units of Distress Scale (SUDS) is the maximum amount of fear experienced rated on a 0 to 100 point scale, where 0 indicates no anxiety and 100 indicates the maximum level of anxiety.'}, {'measure': 'Salivary Testosterone Levels', 'timeFrame': 'Baseline and 20 minutes after posture manipulation', 'description': 'Saliva sample taken before posture manipulation and 20 minutes after. Outcome is the change from pre- to post-manipulation in testosterone levels.'}]}, 'oversightModule': {'oversightHasDmc': True, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['Social Anxiety Disorder']}, 'descriptionModule': {'briefSummary': 'The purpose of this study is to determine whether power posing (i.e., holding poses associated with dominance and power), compared to submissive posing or rest, prior to exposure therapy for social anxiety disorder: 1) leads to a temporary increase in testosterone levels and/or 2) facilitates exposure therapy outcomes.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'maximumAge': '70 Years', 'minimumAge': '18 Years', 'healthyVolunteers': True, 'eligibilityCriteria': "Inclusion Criteria:\n\n* Outpatients between the ages of 18 to 70 years of age with a primary psychiatric diagnosis (designated by the patient as the most important source of current distress) of social anxiety disorder as defined by DSM-5 criteria, with fear of public speaking endorsed as a primary concern.\n* Willingness and ability to participate in the informed consent process and comply with the requirements of the study protocol.\n\nExclusion Criteria:\n\n* Current use of testosterone enhancing products (i.e., gels, creams, or injections)\n* A lifetime history of bipolar disorder, schizophrenia, psychosis, or delusional disorders; organic brain syndrome, mental retardation or other cognitive dysfunction that could interfere with capacity to engage in therapy; a history of substance or alcohol abuse or dependence (other than nicotine) in the last 6 months.\n* Entry of patients with other mood or anxiety disorders will be permitted in order to increase accrual of a clinically relevant sample; however in cases where SAD is not judged to be the predominant disorder, participants will not be eligible.\n* Patients with significant suicidal ideation or who have enacted suicidal behaviors within 6 months prior to intake will be excluded from study participation and referred for appropriate clinical intervention.\n* Patients using psychotropic medication (e.g., antidepressants, anxiolytics, beta blockers) must be on a stable dose for three weeks prior to initiation of randomized treatment.\n* Significant personality dysfunction likely to interfere with study participation.\n* Patients with a current or past history of seizures.\n* Any concurrent psychotherapy initiated within 3 months of baseline, or ongoing psychotherapy of any duration directed specifically toward treatment of the SAD is excluded. Prohibited psychotherapy includes CBT or psychodynamic therapy focusing on exploring specific, dynamic causes of the phobic symptomatology and providing management skills. General supportive therapy initiated \\> 3 months prior is acceptable.\n* Prior non-response to adequately delivered exposure (i.e., as defined by the patient's report of receiving specific and regular exposure assignments as part of a previous treatment).\n* Patients with a history of head trauma causing loss of consciousness, seizure or ongoing cognitive impairment.\n* Subjects with back pain issues or medical conditions that would make it difficult to hold posture manipulations.\n* Insufficient command of the English language."}, 'identificationModule': {'nctId': 'NCT02482805', 'briefTitle': 'Hormones and Social Anxiety Disorder Treatment', 'organization': {'class': 'OTHER', 'fullName': 'University of Texas at Austin'}, 'officialTitle': 'Effect of Hormones on Response to Exposure Therapy for Social Anxiety Disorder', 'orgStudyIdInfo': {'id': 'SAD - Hormones'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Power Posing', 'description': 'Individuals hold two, 1-minute postures associated with dominance and high power prior to exposure therapy.', 'interventionNames': ['Behavioral: Cognitive Behavioral Therapy']}, {'type': 'EXPERIMENTAL', 'label': 'Submissive Posing', 'description': 'Individuals hold two, 1-minute postures associated with submissiveness and low power prior to exposure therapy.', 'interventionNames': ['Behavioral: Cognitive Behavioral Therapy']}, {'type': 'EXPERIMENTAL', 'label': 'Rest', 'description': 'Individuals rest (no postures) for 2 minutes prior to exposure therapy.', 'interventionNames': ['Behavioral: Cognitive Behavioral Therapy']}], 'interventions': [{'name': 'Cognitive Behavioral Therapy', 'type': 'BEHAVIORAL', 'description': 'Exposure therapy for social anxiety disorder', 'armGroupLabels': ['Power Posing', 'Rest', 'Submissive Posing']}]}, 'contactsLocationsModule': {'locations': [{'zip': '78712', 'city': 'Austin', 'state': 'Texas', 'country': 'United States', 'facility': 'University of Texas at Austin', 'geoPoint': {'lat': 30.26715, 'lon': -97.74306}}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'University of Texas at Austin', 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR'}}}}